This webinar has been developed, organised and funded by Novo Nordisk. For healthcare professionals only. Promotional information on insulin degludec (Tresiba®) will be discussed in this webinar.
Click here to view prescribing information for insulin degludec (Tresiba®). Insulin degludec (Tresiba®) is indicated for the treatment of diabetes mellitus in adults, adolescents and children from the age of 1 year.